ConductScience.org, home

Paper20176910

CEM-101 activity against Gram-positive organisms.

Woosley LN and 2 others. Antimicrob Agents Chemother, 2010. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. CEM-101 activity against Gram-positive organisms. Papers, record 20176910. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20176910

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CEM-101 activity against Gram-positive organisms.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2021-10-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woosley LNLeah N
2Castanheira MMariana
3Jones RNRonald N

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Drug Resistance, BacterialMajor topic
Gram-Positive BacteriaMajor topic
MacrolidesMajor topic
TriazolesMajor topic
Azithromycin
Ceftriaxone
Clarithromycin
Drug Synergism
Erythromycin
Gentamicins
Ketolides
Microbial Sensitivity Tests
Ofloxacin
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae
Streptococcus pyogenes
Trimethoprim, Sulfamethoxazole Drug Combination
Vancomycin

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115811021Current and emerging serious Gram-positive infections.Clin Microbiol Infect2005https://conductscience.org/library/papers/15811021PubMed
219085949Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.Hepatology2009https://conductscience.org/library/papers/19085949PubMed
311324679Review of macrolides and ketolides: focus on respiratory tract infections.Drugs2001https://conductscience.org/library/papers/11324679PubMed
419151038
In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
J Antimicrob Chemother2009https://conductscience.org/library/papers/19151038PubMed
515980400Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15980400PubMed
611120939Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11120939PubMed
714519674Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci.J Antimicrob Chemother2003https://conductscience.org/library/papers/14519674PubMed
819164155Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19164155PubMed
915504828Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15504828PubMed
1015056640Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.J Antimicrob Chemother2004https://conductscience.org/library/papers/15056640PubMed
1112149046The ketolides: a critical review.Drugs2002https://conductscience.org/library/papers/12149046PubMed
1219258276Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19258276PubMed
1311062201Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.J Antimicrob Chemother2000https://conductscience.org/library/papers/11062201PubMed
1415109426Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.Emerg Infect Dis2004https://conductscience.org/library/papers/15109426PubMed
1516545937Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci.Diagn Microbiol Infect Dis2006https://conductscience.org/library/papers/16545937PubMed
1616723563DNA microarray for detection of macrolide resistance genes.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16723563PubMed
1712951334Induction of telithromycin resistance in Streptococcus pneumoniae.J Antimicrob Chemother2003https://conductscience.org/library/papers/12951334PubMed
1820211548Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.Int J Antimicrob Agents2010https://conductscience.org/library/papers/20211548PubMed

Download CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42938734Clinical Development of Antibacterial Drugs: Recent Progress and Future Outlook.Antibiotics (Basel)2026https://conductscience.org/library/papers/42938734PubMed
40868007The Current Landscape of Antibiotic Use and Antimicrobial Resistance in Japan: Focusing on Common Infections Including Uncomplicated Urinary Tract Infection and Gonorrhea.Antibiotics (Basel)2025https://conductscience.org/library/papers/40868007PubMed
35745018Dinuclear vs. Mononuclear Copper(II) Coordination Species of Tylosin and Tilmicosin in Non-Aqueous Solutions.Molecules2022https://conductscience.org/library/papers/35745018PubMed
31932436A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/31932436PubMed
30054232How Macrolide Antibiotics Work.Trends Biochem Sci2018https://conductscience.org/library/papers/30054232PubMed
29891609Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29891609PubMed
29608052Modern Approaches for Asymmetric Construction of Carbon-Fluorine Quaternary Stereogenic Centers: Synthetic Challenges and Pharmaceutical Needs.Chem Rev2018https://conductscience.org/library/papers/29608052PubMed
29229833Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/29229833PubMed
28664582The macrolide antibiotic renaissance.Br J Pharmacol2017https://conductscience.org/library/papers/28664582PubMed
27909995Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Drugs2016https://conductscience.org/library/papers/27909995PubMed
27044551Results from the Solithromycin International Surveillance Program (2014).Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27044551PubMed
24900314Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity.ACS Med Chem Lett2011https://conductscience.org/library/papers/24900314PubMed
24379197In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24379197PubMed
24277019Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24277019PubMed
24189250Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24189250PubMed
23318809Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23318809PubMed
22802254Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22802254PubMed
22354296
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?
Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22354296PubMed
21282444Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21282444PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20176910

GET https://conductscience.org/api/papers/v1/20176910/authors